Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.

This study has been completed.
Information provided by:
Gilead Sciences Identifier:
First received: December 23, 2005
Last updated: April 7, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2004
  Estimated Primary Completion Date: No date given